ReviewAnnals of vascular diseases2026
Simple Renal Cysts and Aortic Aneurysms: From Imaging Markers to Prognostic Indicators of Postoperative Outcomes.
Review in Annals of vascular diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Simple renal cysts (SRCs) have traditionally been regarded as benign, age-related incidental findings with limited clinical significance. However, accumulating evidence suggests that SRCs are associated with abdominal aortic aneurysm (AAA), thoracic aortic aneurysm (TAA), and aortic dissection (AD), indicating that they may reflect systemic extracellular matrix (ECM) degeneration rather than isolated renal aging. This narrative review summarizes the current evidence linking SRCs to aortic disease, explores the underlying biological mechanisms, and discusses their potential prognostic significance following endovascular aortic repair. Observational studies have consistently reported a 2- to 3-fold higher prevalence of SRCs in patients with aortic disease compared with controls. Shared mechanisms, including ECM remodeling, matrix metalloproteinase activation, genetic susceptibility, and arterial stiffening, provide biological plausibility for this association. Emerging evidence further suggests that SRCs are independently associated with reduced sac shrinkage after endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR), as well as with an increased risk of aortic-related adverse events following TEVAR for type B AD. Although the current evidence is derived predominantly from retrospective studies, SRCs represent a readily identifiable imaging marker that may enhance risk stratification and postoperative surveillance. Prospective multicenter studies are warranted to validate these findings and clarify their clinical implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.